PETER HOTEZ to Leishmaniasis, Cutaneous
This is a "connection" page, showing publications PETER HOTEZ has written about Leishmaniasis, Cutaneous.
Connection Strength
0.805
-
Cutaneous leishmaniasis and co-morbid major depressive disorder: A systematic review with burden estimates. PLoS Negl Trop Dis. 2019 02; 13(2):e0007092.
Score: 0.147
-
A new perspective on cutaneous leishmaniasis-Implications for global prevalence and burden of disease estimates. PLoS Negl Trop Dis. 2017 08; 11(8):e0005739.
Score: 0.132
-
Expression, purification, immunogenicity and protective efficacy of a recombinant nucleoside hydrolase from Leishmania donovani, a vaccine candidate for preventing cutaneous leishmaniasis. Protein Expr Purif. 2017 02; 130:129-136.
Score: 0.125
-
Old World Cutaneous Leishmaniasis and Refugee Crises in the Middle East and North Africa. PLoS Negl Trop Dis. 2016 05; 10(5):e0004545.
Score: 0.122
-
Combating the next lethal epidemic. Science. 2015 Apr 17; 348(6232):296-7.
Score: 0.113
-
The potential economic value of a cutaneous leishmaniasis vaccine in seven endemic countries in the Americas. Vaccine. 2013 Jan 07; 31(3):480-6.
Score: 0.095
-
A scalable and reproducible manufacturing process for Phlebotomus papatasi salivary protein PpSP15, a vaccine candidate for leishmaniasis. Protein Expr Purif. 2021 01; 177:105750.
Score: 0.041
-
Status of vaccine research and development of vaccines for leishmaniasis. Vaccine. 2016 06 03; 34(26):2992-2995.
Score: 0.030